InnoUp Farma, backed by Sodena, Successfully Completes Phase 1 Trial of INP20, Its Innovative Oral Immunotherapy for Peanut Allergy

by Sodena

Unlike other therapies currently available or under development, INP20 is not designed to desensitise patients to the allergen. Instead, it aims to replicate the biological signals generated by the gu...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

InnoUp Farma, backed by Sodena, Successf...

by Sodena

Unlike other therapies currently available or under development, INP20...

Photos Stream